Skip to main content
CRVS logo

CRVS · Corvus Pharmaceuticals, Inc. · Proposed Sales

Track CRVS — free
$10.44 -0.10 (-0.95%) Q2 2026 earnings call transcript
Market Cap
$886.63M
Shares
84.12M
Volume · Oct 28 603.5K Avg daily vol (3M) 996.23K

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

No Proposed Sales

No Form 144 proposed-sale notices are available for this stock yet.

Key facts CIK 1626971 CUSIP 221015100 13F (30d) 21 filings 21 filers Visit website Investor relations